Form 4: EcoR1 Capital Increases Stake in Zymeworks Inc. Through Multiple Share Purchases

EcoR1 Capital, along with related entities, has increased its holdings in Zymeworks Inc. through a series of common stock purchases between December 24th and December 27th, 2024.

Summary

• EcoR1 Capital, LLC, along with Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P., has reported several transactions involving the purchase of Zymeworks Inc. common stock.
• These transactions occurred between December 24th and December 27th, 2024.
• The purchases were made at weighted average prices, with individual transactions ranging from $13.9473 to $14.50 per share.
• The total number of shares purchased across the three days was 129,309.
• Following these transactions, the total number of shares held by the reporting entities is 14,822,590.
• The reporting entities include EcoR1 Capital, LLC, which is the general partner and investment advisor of private funds, including EcoR1 Capital Fund Qualified, L.P., and Oleg Nodelman, who is the manager and controlling owner of EcoR1.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing, but the increased stake by EcoR1 could be seen as a slightly positive signal.

Positives

• EcoR1 Capital's increased investment in Zymeworks Inc. may indicate confidence in the company's future prospects.
• The multiple purchases suggest a strategic accumulation of shares rather than a single opportunistic buy.

Risks

• The document does not provide any information about the reasons for the purchases, so it is difficult to assess the underlying motivation.
• The document does not provide any information about the future intentions of EcoR1 Capital, so it is difficult to assess the potential impact on the share price.

Management Comments

• The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
• The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.

Industry Context

This document is a standard SEC Form 4 filing, which is required when there are changes in beneficial ownership of a company's securities. It is common for investment firms to make such filings when they increase or decrease their holdings in a company.

Comparison to Industry Standards

• Form 4 filings are a standard part of the regulatory landscape for publicly traded companies, and this filing is consistent with the requirements.
• The level of detail provided in the filing is typical for this type of document, including the transaction dates, prices, and number of shares involved.
• The disclaimer of group membership is also a common practice to avoid potential regulatory implications.

Stakeholder Impact

• The increased stake by EcoR1 Capital could be viewed positively by shareholders, potentially increasing confidence in the company.
• The document does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Zymeworks Inc., EcoR1 Capital, Oleg Nodelman, Share Purchases, Beneficial Ownership, Common Stock, Investment